Skip to main content

Pemphigus News

FDA Approves Genentech’s Rituxan (rituximab) for Pemphigus Vulgaris

South San Francisco, CA – June 7, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Rituxan...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

prednisone, doxycycline, methotrexate, prednisolone, dexamethasone, etanercept, tetracycline